[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-342055-105":59,"doc-detail-342055-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","engineering-dendritic-cell-biomimetic-membrane-as-a-delivery-system-for-tumor-targeted-therapy","Engineering dendritic cell biomimetic membrane as a delivery system for tumor targeted therapy","","Targeted immunotherapies are advancing in clinical cancer care by counteracting tumors’ ability to suppress immune responses. Biomimetic technologies that are minimally immunogenic and highly targeted are addressing delivery challenges and reshaping the tumor immune-suppressive microenvironment to promote immune activation. Dendritic cell (DC) membrane coating of nanoparticles supports targeted delivery through DC-mediated activation of naïve T cells. This review summarizes methods for engineering DC membranes and hybrid DC–tumor membrane fusion for therapeutic nanoparticle encapsulation, highlighting applications and recent advances.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/engineering-dendritic-cell-biomimetic-membrane-as-a-delivery-system-for-tumor-targeted-therapy/342055/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/engineering-dendritic-cell-biomimetic-membrane-as-a-delivery-system-for-tumor-targeted-therapy/342055.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-09","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How do dendritic cell biomimetic membranes support tumor targeted therapy?","Question",{"text":113,"@type":114},"DC membranes coated on nanoparticles enable targeted delivery and leverage DCs’ ability to activate naïve T cells. This can help drive immune activation against tumors.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What does the review focus on regarding engineered DC membranes?",{"text":118,"@type":114},"The review discusses methodologies for crafting DC membranes and strategies for fusing dendritic and tumor cell membranes to encapsulate therapeutic nanoparticles.",{"name":120,"@type":111,"acceptedAnswer":121},"What therapeutic applications are highlighted for DC biomimetic nanosystems?",{"text":122,"@type":114},"The review addresses applications and recent advancements in combating cancer, including antigen presentation–driven immunotherapy and cooperative drug delivery roles in chemotherapy and photodynamic therapies.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},342055,1790284370,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Liu et al. Journal of Nanobiotechnology (2024) 22:663  \n[https://doi.org/10.1186/s12951-024-02913-7](https://doi.org/10.1186/s12951-024-02913-7)  \nJournal of Nanobiotechnology  \n REVIEW Open Access  \nEngineering dendritic cell biomimetic membrane as a delivery system for tumor targeted therapy  \nHuiyang Liu1†, Yiming Lu1†, Jinbao Zong2, Bei Zhang3, Xiaolu Li4, Hongzhao Qi5, Tao Yu4,5* and Yu Li 1*  \nAbstract  \nTargeted immunotherapies make substantial strides in clinical cancer care due to their ability to counteract the tumor’s capacity to suppress immune responses. Advances in biomimetic technology with minimally immunogenic and highly targeted, are addressing issues of targeted drug delivery and disrupting the tumor’s immunosuppressive environment to trigger immune activation. Specifically, the use of dendritic cell (DC) membranes to coat nanoparticles ensures targeted delivery due to DC’s unique ability to activate naiveT cells, spotlighting their role in immunotherapy aimed at disrupting the tumor microenvironment. The potential of DC’s biomimetic membrane to mediate immune activation and target tumors is gaining momentum, enhancing the effectiveness of cancer treatments in conjunction with other immune responses. This review delves into the methodologies behind crafting DC membranes and the fusion of dendritic and tumor cell membranes for encapsulating therapeutic nanoparticles. It explores their applications and recent advancements in combating cancer, offering an all-encompassing perspective on DC biomimetic nanosystems, immunotherapy driven by antigen presentation, and the collaborative efforts of drug delivery in chemotherapy and photodynamic therapies. Current evidence shows promise in augmenting combined therapeutic approaches for cancer treatment and holds translational potential for various cancer treatments in a clinical setting.  \nKeywords Immunotherapy, Dendritic cell biomimetic nanoparticles, Cancer therapy, Cell membrane coating, Hybrid cell membrane  \nGraphical Abstract  \n†Huiyang Liu andYiming Lu have authors contributed equally to this article.  \n*Correspondence: Tao Yu  \nyutao01 [12@qdu.edu.cn](12@qdu.edu.cn)  \nYu Li  \n[liyu11920@hotmail.com](liyu11920@hotmail.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nLiu et al. Journal of Nanobiotechnology (2024) 22:663  \nIntroduction  \nCancer remains a leading cause of mortality worldwide, exhibiting a notably aggressive nature [1, 2]. Projections from the Global Cancer Observatory suggest a grim future, with an estimated 30 million individuals succumbing to the disease annually by the year 2030 [3]. Traditional treatment modalities-surgery, chemotherapy, radiotherapy, phototherapy, and their multimodal integration-continue to be the mainstay in oncological management [4]. However, these conventiona","cbCailYTBqbNu78J","https://ap.wps.com/l/cbCailYTBqbNu78J","pdf",2297271,28,"English","# Introduction\n# Abstract\n# Keywords\n# Graphical Abstract","[{\"question\":\"How do dendritic cell biomimetic membranes support tumor targeted therapy?\",\"answer\":\"DC membranes coated on nanoparticles enable targeted delivery and leverage DCs’ ability to activate naïve T cells. This can help drive immune activation against tumors.\"},{\"question\":\"What does the review focus on regarding engineered DC membranes?\",\"answer\":\"The review discusses methodologies for crafting DC membranes and strategies for fusing dendritic and tumor cell membranes to encapsulate therapeutic nanoparticles.\"},{\"question\":\"What therapeutic applications are highlighted for DC biomimetic nanosystems?\",\"answer\":\"The review addresses applications and recent advancements in combating cancer, including antigen presentation–driven immunotherapy and cooperative drug delivery roles in chemotherapy and photodynamic therapies.\"}]","Engineering dendritic cell biomimetic membrane as a delivery system for tumor targeted therapy | PDF",1790044928,71,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8b5ac82369da1065a45471fcd52f32d9.webp",983,1305,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8db236070d1b06117c78d1d5e0be3ef8.webp",982,1304,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/df604be48725eada1b0f2fc791922b71.webp",981,1303,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/452791e7467d7653a854697b09fa4779.webp",980,1301]